Results 151 to 160 of about 13,968,799 (299)

Rabies Control - towards sustainable prevention at the source : Compendium of the OIE Global Conference on rabies control, 7.-9. September 2011, Incheon-Seoul (Republic of Korea)

, 2012
Global perspective of rabies -- Towards sustainable prevention of rabies at the source : a case report from India -- Rabies in China -- Rabies elimination in Europe : a success story -- Epidemiological factors and control of rabies in North Africa ...

core  

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

Molecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary, Jose Javier Bravo‐Cordero   +1 more
wiley   +1 more source

Neemazal ® as a possible alternative control tool for malaria and African trypanosomiasis? [PDF]

Parasit Vectors, 2016
Yerbanga RS, Rayaisse JB, Vantaux A, Salou E, Mouline K, Hien F, Habluetzel A, Dabiré RK, Ouédraogo JB, Solano P, Lefèvre T.   +10 more
europepmc   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

Molecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska, Stephany Gallardo, Nur S. Zainal, Leena Arora, Matthew Ellis, Maria‐Antoinette Lopez, Judith Austine, Sai Pittla, Serena J Chee, Aiman Alzetani, Emily C Shaw, Christian H Ottensmeier, Gareth J Thomas, Christopher J Hanley   +13 more
wiley   +1 more source

Introduction and testing of an alternative control approach for a robotic prosthetic arm. [PDF]

Open Biomed Eng J, 2014
Griggs L, Fahimi F.
europepmc   +1 more source

Activity Report 2001 [PDF]

Centers for Disease Control and Prevention National Center for Injury Prevention and Control, Division of Unintentional Injury ...
National Center for Injury Prevention and Control (U.S) Division of Unintentional Injury Prevention.
core  

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

Molecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura, Tadahiro Kuribayashi, Johannes Brägelmann, Sachi Okawa, Masataka Taoka, Shunta Mori, Tomoka Nishimura, Takaaki Tanaka, Go Makimoto, Kiichiro Ninomiya, Kammei Rai, Eiki Ichihara, Ryohei Katayama, Katsuyuki Hotta, Masahiro Tabata, Yosuke Togashi, Yoshinobu Maeda, Martin L. Sos, Katsuyuki Kiura, Kadoaki Ohashi   +19 more
wiley   +1 more source

Investigating singing imagery as an additional or alternative control task for EEG-based Brain-Computer Interfaces. [PDF]

Front Hum Neurosci
Mohammadpour H, Power SD.
europepmc   +1 more source

Estimating Influenza Vaccine Effectiveness With the Test-Negative Design Using Alternative Control Groups: A Systematic Review and Meta-Analysis. [PDF]

Am J Epidemiol, 2018
Feng S, Cowling BJ, Kelly H, Sullivan SG.   +3 more
europepmc   +1 more source

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

Molecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis, Jack V. Mills, Wojciech Niedzwiedz, Valentine M. Macaulay   +3 more
wiley   +1 more source